Literature DB >> 20059475

Pattern recognition receptors of innate immunity and their application to tumor immunotherapy.

Tsukasa Seya1, Hiroaki Shime, Takashi Ebihara, Hiroyuki Oshiumi, Misako Matsumoto.   

Abstract

Dendritic cells (DC) begin maturation in response to complex stimuli consisting of antigens and pattern molecules (PAMP) for the activation of the immune system. Immune adjuvant usually contains PAMP. Infection represents one event that is capable of inducing such a complex set of stimuli. Recently, DC were subdivided into a number of subsets with distinct cell-surface markers, with each subset displaying unique differential maturation in response to pattern molecules to induce various types of effector cells. In the present study, we review how pattern recognition molecules and adaptors in each DC subset drive immune effector cells and their effect in the stimulated DC. Although tumor cells harbor tumor-associated antigens, they usually lack PAMP. Hence, we outline the properties of exogenously-added PAMP in the modulation of raising tumor immunity. In addition, we describe the mechanism by which DC-dependent natural killer activation is triggered for the induction of antitumor immunity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20059475     DOI: 10.1111/j.1349-7006.2009.01442.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  11 in total

1.  TRAIL/DR5 plays a critical role in NK cell-mediated negative regulation of dendritic cell cross-priming of T cells.

Authors:  Mitsuhiro Iyori; Tong Zhang; Haddon Pantel; Bethany A Gagne; Charles L Sentman
Journal:  J Immunol       Date:  2011-08-10       Impact factor: 5.422

2.  Polymorphisms of the TLR2 and TLR4 genes are associated with risk of gastric cancer in a Brazilian population.

Authors:  Juliana Garcia de Oliveira; Ana Elizabete Silva
Journal:  World J Gastroenterol       Date:  2012-03-21       Impact factor: 5.742

3.  The peptide sequence of diacyl lipopeptides determines dendritic cell TLR2-mediated NK activation.

Authors:  Masahiro Azuma; Ryoko Sawahata; Yuusuke Akao; Takashi Ebihara; Sayuri Yamazaki; Misako Matsumoto; Masahito Hashimoto; Koichi Fukase; Yukari Fujimoto; Tsukasa Seya
Journal:  PLoS One       Date:  2010-09-02       Impact factor: 3.240

4.  Correlation of Asp299Gly and Thr399Ile polymorphisms in toll-like receptor 4 gene with digestive cancer risk: A meta-analysis.

Authors:  Xinxin Zhao; Shan Kang; Lingling Liu; Dongfeng Zhang
Journal:  Biomed Rep       Date:  2012-10-29

5.  TLR3/TICAM-1 signaling in tumor cell RIP3-dependent necroptosis.

Authors:  Tsukasa Seya; Hiroaki Shime; Hiromi Takaki; Masahiro Azuma; Hiroyuki Oshiumi; Misako Matsumoto
Journal:  Oncoimmunology       Date:  2012-09-01       Impact factor: 8.110

6.  Cross-priming for antitumor CTL induced by soluble Ag + polyI:C depends on the TICAM-1 pathway in mouse CD11c(+)/CD8α(+) dendritic cells.

Authors:  Masahiro Azuma; Takashi Ebihara; Hiroyuki Oshiumi; Misako Matsumoto; Tsukasa Seya
Journal:  Oncoimmunology       Date:  2012-08-01       Impact factor: 8.110

Review 7.  The effects of TLR activation on T-cell development and differentiation.

Authors:  Bo Jin; Tao Sun; Xiao-Hong Yu; Ying-Xiang Yang; Anthony E T Yeo
Journal:  Clin Dev Immunol       Date:  2012-06-07

Review 8.  Modulation of APC Function and Anti-Tumor Immunity by Anti-Cancer Drugs.

Authors:  Kea Martin; Jens Schreiner; Alfred Zippelius
Journal:  Front Immunol       Date:  2015-09-29       Impact factor: 7.561

9.  The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity.

Authors:  Yichuan Xiao; Qiang Zou; Xiaoping Xie; Ting Liu; Haiyan S Li; Zuliang Jie; Jin Jin; Hongbo Hu; Ganiraju Manyam; Li Zhang; Xuhong Cheng; Hui Wang; Isabelle Marie; David E Levy; Stephanie S Watowich; Shao-Cong Sun
Journal:  J Exp Med       Date:  2017-03-29       Impact factor: 14.307

10.  Development of a novel TLR8 agonist for cancer immunotherapy.

Authors:  Yuxun Wang; Heping Yang; Huanping Li; Shuda Zhao; Yikun Zeng; Panpan Zhang; Xiaoqin Lin; Xiaoxiang Sun; Longsheng Wang; Guangliang Fu; Yaqiao Gao; Pei Wang; Daxin Gao
Journal:  Mol Biomed       Date:  2020-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.